Related LncRNAs
ID	lncRNA Name	Disease	Method	Sample	Expression pattern	Dysfunction type	Description	PMID	Source
EL0237	BCYRN1	esophageal cancer	ISH, Northern hybridization etc.	esophageal cancer tissue	up-regulated	expression	BC200 RNA was expressed in carcinomas of the breast, cervix, oesophagus, lung, ovary, parotid, and tongue, but not in corresponding normal tissues.	9422992	LncRNADisease Lnc2Cancer
EL0556	H19	esophageal cancer	qPCR, Western blot, knockdown etc.	esophageal cancer tissue, cell lines (TE-1, TE-10, Eca-1, Eca-109, KYSE1170)	up-regulated	expression	The expression of H19 was significantly increased and associated with tumor depth and metastasis in 133 EC samples. In addition, it was identified that an upregulation of H19 induced epithelial-to-mesenchymal transition. In conclusion, H19 has a significant role in the development of EC and may serve as a potential prognostic marker and therapeutic target for EC.	26171017	Lnc2Cancer
EL1063	PEG10	esophageal cancer	qPCR, Western blot etc.	esophageal cancer tissue, cell lines (EC9706, KYSE150)	up-regulated	expression	LncRNA PEG10 was expressed at higher levels in esophageal cancer tissues than in adjacent non-neoplastic tissues (P<0.05). This relatively high expression was significantly associated with the occurrence of lymph node metastases (P<0.05). Apoptosis and migration rates were significantly decreased in two esophageal cancer cell lines (EC9706 and KYSE150) transfetced with si-LncRNA PEG10 (P<0.05).	25591808	Lnc2Cancer